全球髓内髋螺钉市场：市场规模、份额和趋势分析（2025-2031 年）

2024年全球髓内髋螺钉市场价值为11亿美元。预计该市场将持续成长，到2031年将达到13亿美元。

本报告涵盖全球髓内髋螺钉市场的所有产品细分市场，包括钛合金和不銹钢髓内髋螺钉。报告量化了销量、平均售价（ASP）、市场规模、成长率和企业市场占有率。此外，报告还分析了市场驱动因素和限制因素、近期併购、手术技术趋势和技术发展。本研究提供截至2021年的历史资料以及截至2031年的预测资料。

市场概览

髓内髋螺钉已成为股骨粗隆间和粗隆下骨折内固定的全球标准。其动态设计提供了卓越的稳定性，与传统髋螺钉相比，可使患者更早活动并促进骨折癒合。髓内固定的持续普及反映了外科医生对这些系统临床可靠性和良好治疗效果日益增长的信心。

全球市场受人口老化导致髋部骨折发生率上升的驱动，尤其是在北美、欧洲和亚太部分地区。老年患者容易发生低能量损伤和脆性骨折，而这些损伤和骨折仍是造成老年患者发病率和医疗成本的主要原因。医院和创伤中心持续优先采用兼具强度、可重复性和低併发症率的医疗器材。

与钢板固定相比，髓内螺钉具有更高的旋转稳定性、更均匀的轴向负载分布和更可控的骨折加压效果。这些优势降低了再次手术率和术后併发症，使其在已开发市场和新兴市场中持续应用。

材料成分仍然是采购决策的核心因素。钛合金髓内螺丝因其重量轻、生物相容性好、耐腐蚀和抗疲劳等优点而占据市场主导地位。主要製造商持续加大研发投入，推动新型钛合金的开发，进而提供更高的强度和耐久性。不銹钢螺丝在高负荷应用和对成本敏感的市场中仍然使用，但随着钛合金系统价格的降低，其市场份额正在逐渐下降。

在全球范围内，IM髋螺钉市场受益于其在创伤护理中的关键作用，创伤护理是一种紧急手术，无论经济状况如何都需要进行，这一特点稳定了需求并限制了宏观经济衰退的影响。

市场驱动因素

髓内螺丝越来越受欢迎

过去十年间，股骨近端骨折的治疗标准已从钢板和传统螺丝固定转向髓内髋关节螺钉固定。这些系统兼具强度、稳定性和可控骨折加压的优点，使患者能够早期负重并促进復原。

儘管骨内螺钉的平均售价通常高于传统固定方法，但其显着改善的临床疗效足以证明其成本合理。由于再次手术率更低、住院时间更短，医院越来越认可骨内螺钉是治疗股骨粗隆间骨折和股骨粗隆下骨折最具成本效益的选择。

植入几何形状、锁定机制和器械的不断改进进一步增强了这种临床偏好。现代设计提高了植入精度，缩短了手术时间，并降低了术中骨折和器械故障的风险。随着培训计画和整形外科课程越来越重视髓内固定技术，该手术在该地区的应用也持续成长。

在基本外科手术中的作用

股骨近端创伤性骨折和脆弱性骨折需在急诊手术中透过股骨内螺钉治疗。由于此类手术的紧急性，儘管经济週期波动和医院资本预算变化，其需求仍保持稳定。

由于髋部骨折治疗的必要性，手术数量与人口因素密切相关，而非可支配支出。随着全球预期寿命的延长和人口老化，髋部骨折的发生率预计将稳定上升，尤其是在医疗体系成熟的地区。这一人口趋势支撑了髋关节内螺钉市场的长期需求稳定性。

良好的临床结果

临床研究一致表明，对于股骨内侧和股骨粗隆下骨折，髓内髋关节螺钉固定优于传统固定方法。髓内植入的负荷分担结构允许早期活动，从而改善復健效果并降低併发症发生率。

这种设计允许在骨折部位进行可控滑动，促进自然加压，并降低植入失效的风险。这种动态优势使得髓内螺钉在世界各地的许多医院几乎完全取代了传统的髋关节螺钉系统。随着降低再次手术率的数据不断积累，外科医生继续选择髓内螺钉，因为它们具有可靠性和长期疗效。

市场限制

平均售价（ASP）下降

儘管手术量保持稳定，但整形外科创伤植入的平均售价仍持续受到集团采购组织 (GPO)、政府采购和基于价值的采购倡议的压力。这些采购模式集中需求并优先考虑价格竞争，削弱了製造商维持高价的能力，即使在特殊植入领域也是如此。

中国等地区在2021年实施国家采购政策后，价格出现了显着下降。西欧和北美也出现了类似的趋势，当地医院正利用集体谈判来协商产品标准化和批量折扣。随着时间的推移，儘管采购量持续增长，但这种趋势将限制价格成长。

髋关节置换术的发展

关节重组技术的进步对髋关节髓内螺钉构成了间接竞争。由于植入材料的改进、模组化设计的运用以及手术技术的精进，全髋关节置换和部分置换术的可靠性置换术提高。

随着关节置换疗效的提高，一些外科医生在治疗复杂骨折时，尤其是对于患有骨质疏鬆症且功能预后较差的老年患者，倾向于选择全髋置换术而非内固定。这种临床转变可能会导致接受内固定螺丝治疗的患者群体缩小，尤其是在拥有先进关节置换技术的三级医疗中心。

虽然髓内螺钉仍然是治疗大多数股骨粗隆间骨折的标准方法，但老年人髋关节置换术置换术的长期趋势阻碍因素了其发展。

手术併发症

儘管骨内螺丝可提供优异的力学效果，但其植入需要更高的手术精度和经验。植入点和轨迹必须经过仔细规划，并且在植入螺丝前必须达到充分的骨折復位。与传统螺丝系统相比，这些步骤增加了手术时间和复杂性。

此外，接受股骨髓内钉固定的患者可能会出现术后大腿疼痛，尤其是在使用两枚远端锁定螺钉或髓内钉延伸至股骨干的情况下。虽然这些併发症是可以控制的，但外科医师在选择固定方案时仍需考虑这些因素。

儘管培训计划和设备的改进正在缓解这些挑战，但手术的复杂性仍然是资源有限的医院广泛采用该手术的障碍。

目标市场和数据范围

• 目标时期：基准年2024年，预测期间2025-2031年，历史资料2021-2023年
• 医疗机构：医院、创伤中心、整形外科手术中心
• 调查方法：市场价值透过销售量乘以平均售价（ASP）计算得出，并透过手术量、医院采购数据和进出口记录进行检验。

市场区隔摘要

• 髓内髋螺钉市场－进一步细分为以下几个部分：
• 按材质：不锈钢和钛
• 量化指标：市场规模、市占率、预测、成长率、销售量、平均售价。
• 定性内容：市场成长趋势、市场限制、主要竞争对手的竞争和 SWOT 分析、併购、公司简介、产品系列、颠覆性技术、疾病概况。
• 资料来源：对行业领导者的直接访谈、监管和政府资料、医院采购记录以及 iData Research 的内部资料库。

竞争分析

史赛克

2024年，史赛克公司在全球髓内髋关节螺钉市场占据领先地位。该公司的Gamma®髓内钉系统长期以来因其重新定义股骨近端骨折的治疗方法并推动市场摆脱传统髋螺钉的束缚而备受认可。 Gamma®产品系列强大的临床应用记录、广泛的全球供应链以及精简的器械，巩固了其持续的领先地位。史赛克公司与创伤中心和分销商建立了牢固的合作关係，进一步强化了其市场领先地位。

德普合成公司

DePuy Synthes凭藉其全面的产品组合，包括PFNA®、TFN®和TFNA®（钛合金股骨大转子锁定髓内钉高级版）系统，在全球市场份额排名第二。这些器械旨在为股骨近端骨折提供可靠的固定和可控的加压。 DePuy Synthes受益于值得信赖的品牌、丰富的临床数据以及与包括钢板、螺丝和髓内系统在内的广泛创伤产品组合的整合。对创新钛基技术的持续投资预计将进一步推动市场份额的扩大。

史密斯和内夫

史密斯-内普公司（Smith & Nephew）占据髓内髋螺钉市场第三大份额，主要归功于其TRIGEN INTERTAN®前股骨大转子固定钉。这种双螺丝整合系统可对骨折进行可控加压固定，并提高旋转稳定性。该公司成长较为稳健，而TRIGEN INTERTAN®系统凭藉其可靠性和广泛应用，为其在高度集中的市场中保持稳定的份额奠定了基础。

技术与临床实务的趋势

• 钛合金创新：对钛合金和混合合金的持续研究和开发提高了抗疲劳性和植入耐久性。
• 短钉：短钉结构可减轻股骨干的压力，进而减少大腿疼痛的发生率。
• 先进的锁定机构：多向锁定係统提供更高的旋转和轴向稳定性。
• 改良的器械：符合人体工学的目标定位装置和扩孔器简化了手术流程，缩短了手术时间。
• 微创技术：经皮方法和改进的标靶装置可减少组织损伤和出血。
• 术后镇痛：新设计旨在透过优化远端锁定结构来减轻大腿疼痛。

附录简称调查方法。

目录

图表清单

图表列表

调查方法

全球关税的影响

髓内髋关节螺丝市场

• 执行摘要
  • 全球髓内髋螺钉市场概览
  • 竞争分析
  • 流程分段
  • 市场区隔
  • 目标区域
• 介绍
• 手术次数
  • 全髋关节髓内螺丝手术
• 市场概览
  • 按细分市场
  • 按地区
• 市场分析与预测
  • 全髋关节髓内螺丝市场
  • 不銹钢髓内髋关节螺丝市场
  • 钛合金髓内髋螺钉市场
• 驾驶员和约束装置
• 竞争市占率分析

简称

The global intramedullary (IM) hip screw market was valued at $1.1 billion in 2024. The market is projected to grow, reaching $1.3 billion by 2031.

This report covers the full suite of products in the global IM hip screw market, including titanium and stainless-steel IM hip screws. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and analyzes market drivers and limiters, recent mergers and acquisitions, procedure trends, and technology developments. The study provides historical data to 2021 and forecasts through 2031.

Market Overview

Intramedullary hip screws have become the global standard for internal fixation of intertrochanteric and subtrochanteric fractures of the femur. Their biomechanical design provides superior stability, allowing earlier patient mobilization and improved fracture healing compared to conventional hip screw constructs. The continued shift toward intramedullary fixation reflects growing confidence among surgeons in the clinical reliability and favorable outcomes of these systems.

The global market is driven by increasing hip fracture incidence due to aging populations, particularly in North America, Europe, and parts of Asia-Pacific. Elderly patients are more prone to low-energy trauma and fragility fractures, which remain a major cause of morbidity and healthcare cost. Hospitals and trauma centers continue to prioritize devices that combine strength, reproducibility, and reduced complication rates.

Compared with plate-based fixation, IM hip screws provide enhanced rotational stability, axial load distribution, and controlled fracture impaction. These features reduce reoperation rates and postoperative complications, which supports continued adoption across developed and emerging markets.

Material composition remains a central factor in purchasing decisions. Titanium IM screws dominate the market because of their light weight, biocompatibility, and resistance to corrosion and fatigue. New titanium alloys are under development to further enhance strength and durability, reflecting ongoing R&D investment from major manufacturers. Stainless steel screws retain use in high-load cases and cost-sensitive markets but are gradually losing share as titanium systems become more affordable.

Globally, the IM hip screw market benefits from its essential role in trauma care, where procedures are non-elective and must proceed regardless of economic conditions. This dynamic stabilizes demand and limits exposure to macroeconomic downturns.

Market Drivers

Growth in Popularity of Intramedullary Screws

Over the past decade, treatment standards for proximal femoral fractures have shifted decisively from plate and conventional screw constructs toward intramedullary hip screws. These systems offer a superior combination of strength, stability, and controlled fracture compression, enabling patients to bear weight earlier and recover faster.

Although IM hip screws typically carry a higher ASP than conventional constructs, the improved clinical outcomes justify their cost. Hospitals increasingly view them as the most cost-effective option for managing intertrochanteric and subtrochanteric fractures due to reduced reoperation rates and shorter hospital stays.

This clinical preference is reinforced by continuous refinement of implant geometry, locking mechanisms, and instrumentation. Modern designs improve insertion accuracy, reduce operative time, and decrease the risk of intraoperative fracture or hardware failure. As training programs and orthopedic curricula emphasize IM fixation techniques, procedural adoption continues to rise across all regions.

Role in Essential Surgery

IM hip screws are used in non-elective surgeries that address traumatic or fragility fractures of the proximal femur. Because these procedures are urgent, demand remains steady regardless of economic cycles or changes in hospital capital budgets.

The essential nature of hip fracture treatment means that procedural volumes are closely tied to demographic factors rather than discretionary spending. As global life expectancy rises and populations age, the frequency of hip fractures is expected to increase steadily, particularly in regions with mature healthcare systems. This demographic trend underpins long-term demand stability in the IM hip screw market.

Favorable Clinical Outcomes

Clinical research consistently demonstrates that IM hip screws outperform traditional fixation methods for intertrochanteric and subtrochanteric fractures. The intramedullary placement provides a load-sharing construct that allows early mobilization, leading to improved rehabilitation and lower complication rates.

The design enables controlled sliding at the fracture site, facilitating natural compression and reducing the risk of implant failure. This biomechanical advantage explains why IM hip screws have almost completely replaced conventional hip screw systems in many hospitals worldwide. As data on reduced reoperation rates accumulate, surgeons continue to prefer IM constructs for their reliability and long-term performance.

Market Limiters

ASP Decreases

Despite stable procedural demand, ASPs for orthopedic trauma implants remain under pressure from group purchasing organizations (GPOs), government tenders, and value-based procurement initiatives. These purchasing models aggregate demand and prioritize price competition, reducing the ability of manufacturers to sustain premiums even in specialized implant categories.

Regions such as China have seen particularly steep price declines following the rollout of national procurement policies in 2021. Similar dynamics affect Western Europe and North America, where hospitals leverage collective bargaining to standardize products and negotiate volume discounts. Over time, this trend limits value growth despite consistent unit expansion.

Growth of Hip Replacement

Advances in joint reconstruction are creating indirect competition for IM hip screws. Total and partial hip replacements have become increasingly reliable, with improved implant materials, modular designs, and refined surgical techniques.

As outcomes for arthroplasty procedures improve, some surgeons prefer hip replacement over internal fixation for complex fractures, particularly in elderly patients with osteoporotic bone or poor functional prognosis. This clinical shift reduces the potential pool of candidates for IM screw fixation, particularly in tertiary care centers with high arthroplasty expertise.

Although IM screws remain the standard for most intertrochanteric fractures, the long-term trend toward greater use of hip replacements in elderly populations represents a limiting factor for growth.

Increased Surgical Complexity

While IM hip screws deliver superior mechanical results, their insertion requires greater surgical precision and experience. The entry point and trajectory must be carefully planned, and proper fracture reduction must be achieved before nail insertion. These steps add time and complexity to the operation compared to conventional hip screw systems.

Additionally, patients implanted with IM hip nails may experience postoperative thigh pain, especially when constructs use two distal locking screws or when the nail extends into the diaphysis. Although such complications are manageable, they remain a consideration when surgeons evaluate fixation options.

Training programs and improved instrumentation continue to mitigate these challenges, but surgical complexity remains a barrier to universal adoption in lower-resource hospitals.

Market Coverage and Data Scope

• Time Frame: Base year 2024, forecasts 2025-2031, and historical data 2021-2023.
• Care Settings: Hospitals, trauma centers, and orthopedic surgical facilities.
• Methodology: Market values derived from unit sales X ASP, validated through procedure volumes, hospital purchasing data, and import/export records.

Market Segmentation Summary

• Intramedullary Hip Screw Market - Further Segmented Into:
• Material Type: Stainless Steel and Titanium
• Quantitative Coverage: Market size, market shares, forecasts, growth rates, units sold, and average selling prices.
• Qualitative Coverage: Market growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews.
• Data Sources: Primary interviews with industry leaders, regulatory and government data, hospital procurement records, and iData Research's internal database.

Competitive Analysis

Stryker

Stryker was the leading company in the global intramedullary hip screw market in 2024. The company's Gamma(R) Nail System has long been recognized for redefining the treatment of proximal femoral fractures and shifting the market away from conventional hip screws. The Gamma(R) portfolio's strong clinical record, combined with broad global availability and streamlined instrumentation, ensures continued leadership. Stryker's established relationships with trauma centers and distributors reinforce its position at the top of the market.

DePuy Synthes

DePuy Synthes ranked second globally, supported by its comprehensive product suite, including the PFNA(R), TFN(R), and TFNA(R) (Titanium Trochanteric Fixation Nail Advanced) systems. These devices are designed for reliable fixation and controlled compression in proximal femoral fractures. DePuy Synthes benefits from brand trust, extensive clinical documentation, and integration with its broader trauma portfolio, which includes plates, screws, and intramedullary systems. Continued investment in titanium-based innovations is expected to support incremental market share gains.

Smith & Nephew

Smith & Nephew held the third-largest share in the IM hip screw market, primarily through its TRIGEN INTERTAN(R) Intertrochanteric Antegrade Nail. This dual integrated screw system allows controlled fracture impaction and enhanced rotational stability. While Smith & Nephew's growth has been modest, the TRIGEN INTERTAN(R) remains a reliable and widely used system that supports a stable share position in a highly consolidated market.

Technology and Practice Trends

• Titanium Alloy Innovation: Ongoing R&D in titanium and hybrid alloys improves fatigue resistance and implant longevity.
• Shorter Nails: Shorter constructs reduce stress on the femoral shaft and lower thigh pain rates.
• Advanced Locking Options: Multidirectional locking systems enhance rotational and axial stability.
• Instrumentation Upgrades: Ergonomic targeting devices and reamers streamline procedures and reduce operating time.
• Minimally Invasive Techniques: Percutaneous approaches and improved targeting reduce tissue trauma and blood loss.
• Postoperative Pain Reduction: New designs aim to mitigate thigh pain through optimized distal locking configurations.

Methodology Appendix and Acronym Glossary included.

Why This Report

Where are the largest and fastest-growing regions within the global IM hip screw market through 2031.

How titanium innovation and material shifts are shaping product design, cost, and competitiveness.

Which companies are leading and how their portfolios compare by feature, reach, and performance.

How GPOs, tenders, and procurement models influence pricing and adoption.

How hip replacement trends are impacting fracture fixation decisions and patient management.

What design innovations reduce operative complexity and postoperative complications.

The Global Intramedullary Hip Screw Market Report from iData Research answers these questions with device-level analysis, company share tracking, and pricing benchmarks.

It enables stakeholders to quantify demand, evaluate competition, and plan commercial strategy across material and regional segments.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Intramedullary Hip Screw Market

• 8.1 Executive Summary
  • 8.1.1 Global Intramedullary Hip Screw Market Overview
  • 8.1.2 Competitive Analysis
  • 8.1.3 Procedure Segmentation
  • 8.1.4 Market Segmentation
  • 8.1.5 Regions Included
• 8.2 Introduction
• 8.3 Procedure Numbers
  • 8.3.1 Total Intramedullary Hip Screw Procedures
• 8.4 Market Overview
  • 8.4.1 By Segment
  • 8.4.2 By Region
• 8.5 Market Analysis And Forecast
  • 8.5.1 Total Intramedullary Hip Screw Market
  • 8.5.2 Stainless-Steel Intramedullary Hip Screw Market
  • 8.5.3 Titanium Intramedullary Hip Screw Market
• 8.6 Drivers And Limiters
  • 8.6.1 Market Drivers
  • 8.6.2 Market Limiters
• 8.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 8-1: Intramedullary Hip Screw Market, Global, 2024 & 2031
• Chart 8-2: Intramedullary Hip Screw Procedures, Global, 2024
• Chart 8-3: Intramedullary Hip Screw Procedures by Region, Global, 2021 - 2031
• Chart 8-4: Intramedullary Hip Screw Market by Segment, Global, 2021 - 2031
• Chart 8-5: Intramedullary Hip Screw Market by Region, Global, 2021 - 2031
• Chart 8-6: Leading Competitors, Intramedullary Hip Screw Market, Global, 2024

LIST OF FIGURES

• Figure 8-1: Intramedullary Hip Screw Procedure Segmentation
• Figure 8-2: Intramedullary Hip Screw Market Segmentation
• Figure 8-3: Intramedullary Hip Screw Regions Covered, Global (1 of 2)
• Figure 8-4: Intramedullary Hip Screw Regions Covered, Global (2 of 2)
• Figure 8-5: Intramedullary Hip Screw Procedures by Region, Global, 2021 - 2031
• Figure 8-6: Intramedullary Hip Screw Procedures by Country, North America, 2021 - 2031
• Figure 8-7: Intramedullary Hip Screw Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
• Figure 8-8: Intramedullary Hip Screw Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
• Figure 8-9: Intramedullary Hip Screw Procedures by Country, Western Europe, 2021 - 2031
• Figure 8-10: Intramedullary Hip Screw Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
• Figure 8-11: Intramedullary Hip Screw Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
• Figure 8-12: Intramedullary Hip Screw Procedures by Country, Middle East, 2021 - 2031
• Figure 8-13: Intramedullary Hip Screw Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
• Figure 8-14: Intramedullary Hip Screw Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
• Figure 8-15: Intramedullary Hip Screw Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
• Figure 8-16: Intramedullary Hip Screw Procedures by Country, Africa, 2021 - 2031
• Figure 8-17: Intramedullary Hip Screw Market by Segment, Global, 2021 - 2031 (US$M)
• Figure 8-18: Intramedullary Hip Screw Market by Region, Global, 2021 - 2031 (US$M)
• Figure 8-19: Intramedullary Hip Screw Market, Global, 2021 - 2031
• Figure 8-20: Units Sold by Region, Intramedullary Hip Screw Market, Global, 2021 - 2031
• Figure 8-21: Average Selling Price by Region, Intramedullary Hip Screw Market, Global, 2021 - 2031 (US$)
• Figure 8-22: Market Value by Region, Intramedullary Hip Screw Market, Global, 2021 - 2031 (US$M)
• Figure 8-23: Stainless-Steel Intramedullary Hip Screw Market, Global, 2021 - 2031
• Figure 8-24: Units Sold by Region, Stainless-Steel Intramedullary Hip Screw Market, Global, 2021 - 2031
• Figure 8-25: Average Selling Price by Region, Stainless-Steel Intramedullary Hip Screw Market, Global, 2021 - 2031 (US$)
• Figure 8-26: Market Value by Region, Stainless-Steel Intramedullary Hip Screw Market, Global, 2021 - 2031 (US$M)
• Figure 8-27: Titanium Intramedullary Hip Screw Market, Global, 2021 - 2031
• Figure 8-28: Units Sold by Region, Titanium Intramedullary Hip Screw Market, Global, 2021 - 2031
• Figure 8-29: Average Selling Price by Region, Titanium Intramedullary Hip Screw Market, Global, 2021 - 2031 (US$)
• Figure 8-30: Market Value by Region, Titanium Intramedullary Hip Screw Market, Global, 2021 - 2031 (US$M)
• Figure 8-31: Leading Competitors, Intramedullary Hip Screw Market, Global, 2024